Vapotherm, Inc. is the inventor of high flow nasal cannula, and its advanced form: Vapotherm high velocity therapy. Delivering high velocity therapy, the Precision Flow® system offers clinicians a reliable tool for multiple patient populations. For respiratory distress patients presenting in the ED and ICU, high velocity therapy can provide not just oxygenation, but also Mask-Free NIV®—ventilatory support with the comfort of heated humidified high flow. Vapotherm, Inc. is a publicly traded company and listed on the NYSE under the ticker symbol "VAPO."